Online lifestyle platform for mild cognitive impairment and subjective cognitive decline
BreinZorg: A Feasibility Study Into an Online Lifestyle Platform for Mild Cognitive Impairment (MCI) and Subjective Cognitive Decline (SCD)
NA · Radboud University Medical Center · NCT06309758
This study tests whether an online lifestyle platform can help people with mild cognitive impairment or subjective cognitive decline manage their condition and possibly lower their risk of dementia.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 61 Years and up |
| Sex | All |
| Sponsor | Radboud University Medical Center (other) |
| Locations | 1 site (Nijmegen, Gelderland) |
| Trial ID | NCT06309758 on ClinicalTrials.gov |
What this trial studies
This study investigates the feasibility of an online lifestyle platform designed for individuals diagnosed with mild cognitive impairment (MCI) or subjective cognitive decline (SCD). The platform aims to provide users with information and strategies to manage their condition and potentially reduce the risk of developing dementia. Participants will be recruited from memory clinics and will engage with the platform over a six-month period to assess its usability and effectiveness. The study focuses on addressing the knowledge gap for patients who often leave consultations with unanswered questions about their condition.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals over 60 years old who have recently been diagnosed with MCI or SCD and have access to the internet.
Not a fit: Patients diagnosed with dementia or major depression, or those unable to complete a six-month follow-up, may not benefit from this study.
Why it matters
Potential benefit: If successful, this platform could empower patients with MCI and SCD to adopt healthier lifestyles that may lower their risk of developing dementia.
How similar studies have performed: While there is ongoing research into lifestyle interventions for cognitive decline, this specific online platform approach is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Visited a memory clinic; * Recent (no longer than 4 months) diagnosis of MCI or SCD according to the guidelines used in the memory clinic; * \>60 years of age; * Sufficient fluency in Dutch; * Internet access at home and a working e-mail address; * Sufficient hearing and vision to read, watch and hear content on the website. Exclusion Criteria: * Diagnosis of Dementia according to the guidelines of the memory clinic; * Any condition to hinder successful 6-month follow-up; * Diagnosis of Major depression; * Coincident participation in any other intervention trial at time of pre-screening.
Where this trial is running
Nijmegen, Gelderland
- Radboud university medical center — Nijmegen, Gelderland, Netherlands (RECRUITING)
Study contacts
- Study coordinator: Tanya Palsma, MSc
- Email: tanya.palsma@radboudumc.nl
- Phone: 024-3639609
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Mild Cognitive Impairment, Cognitive Decline